Why should investors risk buying before top-line is released? 

Here's the scenario (that I hope we'll see)...stock halted at $4.13 to release top-line data.  APABETALONE ACHIEVES 55% RRR MACE.  Stock starts to trade again at $50.00.....that's why. 

That being said, I know almost for certain based on previous trading patterns before significant news that there is some shady trading going on with RVX.  I'm pretty certain the outcome will be telegraphed prior to the stock being halted and top-line results being made public.  Let's hope it's to the upside.

The recent spike was due to the P&D article IMO.

Buy now to avoid disappointment!

All IMHO.  GLTA...we're almost there :)